David Tenenbaum, 608-265-8549, djtenenb@wisc.edu
Large study shows females are equal to males in math skills
2010-10-13
(Press-News.org) MADISON — The mathematical skills of boys and girls, as well as men and women, are substantially equal, according to a new examination of existing studies in the current online edition of journal Psychological Bulletin.
One portion of the new study looked systematically at 242 articles that assessed the math skills of 1,286,350 people, says chief author Janet Hyde, a professor of psychology and women's studies at the University of Wisconsin-Madison.
These studies, all published in English between 1990 and 2007, looked at people from grade school to college and beyond. A second portion of the new study examined the results of several large, long-term scientific studies, including the National Assessment of Educational Progress.
In both cases, Hyde says, the difference between the two sexes was so close as to be meaningless.
Sara Lindberg, now a postdoctoral fellow in women's health at the UW-Madison School of Medicine and Public Health, was the primary author of the meta-analysis in Psychological Bulletin.
The idea that both genders have equal math abilities is widely accepted among social scientists, Hyde adds, but word has been slow to reach teachers and parents, who can play a negative role by guiding girls away from math-heavy sciences and engineering. "One reason I am still spending time on this is because parents and teachers continue to hold stereotypes that boys are better in math, and that can have a tremendous impact on individual girls who are told to stay away from engineering or the physical sciences because 'Girls can't do the math.'"
Scientists now know that stereotypes affect performance, Hyde adds. "There is lots of evidence that what we call 'stereotype threat' can hold women back in math. If, before a test, you imply that the women should expect to do a little worse than the men, that hurts performance. It's a self-fulfilling prophecy.
"Parents and teachers give little implicit messages about how good they expect kids to be at different subjects," Hyde adds, "and that powerfully affects their self-concept of their ability. When you are deciding about a major in physics, this can become a huge factor."
Hyde hopes the new results will slow the trend toward single-sex schools, which are sometimes justified on the basis of differential math skills. It may also affect standardized tests, which gained clout with the passage of No Child Left Behind, and tend to emphasize lower-level math skills such as multiplication, Hyde says. "High-stakes testing really needs to include higher-level problem-solving, which tends to be more important in jobs that require math skills. But because many teachers teach to the test, they will not teach higher reasoning unless the tests start to include it."
The new findings reinforce a recent study that ranked gender dead last among nine factors, including parental education, family income, and school effectiveness, in influencing the math performance of 10-year-olds.
Hyde acknowledges that women have made significant advances in technical fields. Half of medical school students are female, as are 48 percent of undergraduate math majors. "If women can't do math, how are they getting these majors?" she asks.
Because progress in physics and engineering is much slower, "we have lots of work to do," Hyde says. "This persistent stereotyping disadvantages girls. My message to parents is that they should have confidence in their daughter's math performance. They need to realize that women can do math just as well as men. These changes will encourage women to pursue occupations that require lots of math."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
Study supports the long-term benefits of transcranial magnetic stimulation for depression
2010-10-13
(CHICAGO)–In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.
TMS therapy is a non-invasive technique that delivers highly focused magnetic field pulses to a specific portion of the brain, the left prefrontal cortex, in order to stimulate ...
Adding cetuximab to chemotherapy doubles response rate in hard-to-treat breast cancer
2010-10-13
European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.
At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, the researchers presented results from a Phase-II randomized trial showing that adding the anti-EGFR antibody cetuximab to cisplatin chemotherapy doubled the response rate and time to progression when compared to cisplatin chemotherapy given alone in a study of 173 heavily pre-treated ...
Early research reveals new clues to origin of diabetes
2010-10-13
ANN ARBOR, Mich. – University of Michigan scientists have identified events inside insulin-producing pancreatic cells that set the stage for a neonatal form of non-autoimmune type 1 diabetes, and may play a role in type 2 diabetes as well. The results point to a potential target for drugs to protect normally functioning proteins essential for producing insulin.
A study published online today in the journal PLoS One shows that certain insulin gene mutations involved in neonatal diabetes cause a portion of the proinsulin proteins in the pancreas' beta cells to misfold. ...
Global research effort leads to new findings on genes and obesity
2010-10-13
October 10, 2010─(BRONX, NY) ─Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
"These studies ...
NFL players with concussions now sidelined longer
2010-10-13
Los Angeles, CA (October 11, 2010) NFL players with concussions now stay away from the game significantly longer than they did in the late 1990s and early 2000s, according to research in Sports Health (owned by American Orthopaedic Society for Sports Medicine and published by SAGE). The mean days lost with concussion increased from 1.92 days during 1996-2001 to 4.73 days during 2002-2007.
In an effort to discover whether concussion injury occurrence and treatment had changed, researchers compared those two consecutive six-year periods to determine the circumstances of ...
Abiraterone acetate improves survival in metastatic castration-resistant prostate cancer
2010-10-13
Patients with metastatic castration-resistant prostate cancer who have progressed after chemotherapy live significantly longer if treated with the drug abiraterone acetate compared to placebo, the results of a large Phase-III clinical trial confirm.
"This is a major step forward in prostate cancer therapeutics," said Dr Johann de Bono from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust in London, who presented the study results at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. "Patients in this Phase-III ...
Fertility concerns of cancer survivors inadequately addressed, study finds
2010-10-13
Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.
Professor Bogda Koczwara from Flinders Medical Centre in Adelaide said that fertility concerns among cancer survivors was a growing problem, due to a combination of improved cancer treatment outcomes in young cancer survivors ...
Re-evaluating the time of your life
2010-10-13
In life, we're told, we must take the good with the bad, and how we view these life events determines our well-being and ability to adjust. But according to Prof. Dov Shmotkin of Tel Aviv University's Department of Psychology, you need more than the right attitude to successfully negotiate the vicissitudes of life.
As recently reported in Aging and Mental Health, Prof. Shmotkin's research reveals that people's well-being and their adaptation can be ascertained by their "time trajectory" ― their concept of how they have evolved through their remembered past, currently ...
Sexual issues a major concern for cancer patients taking new targeted drugs
2010-10-13
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.
At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, French researchers reported on one of the few studies to investigate the impact of cancer therapy on the sexual functioning of patients.
Dr Yohann Loriot and Dr Thomas Bessede from Institut Gustave Roussy in Villejuif, France and colleagues found that patients taking ...
Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors
2010-10-13
Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib, the results of a Phase IIb/III trial show.
At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Vincent Miller from Memorial Sloan-Kettering Cancer Center in New York, USA, reported findings from the LUX-Lung 1 trial of afatinib in 585 patients with lung adenocarcinoma whose cancer had progressed after chemotherapy ...